Association between 25‐OH vitamin D and insulin is independent of lipoatrophy in HIV
暂无分享,去创建一个
[1] T. Clemens,et al. The osteoblast: An insulin target cell controlling glucose homeostasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] J. Fox,et al. Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. , 2011, AIDS research and human retroviruses.
[3] D. Nolan,et al. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] F. Ibrahim,et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase , 2010, AIDS.
[5] D. D. de Luis,et al. Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients. , 2010, European review for medical and pharmacological sciences.
[6] H. Bischoff-Ferrari,et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients , 2010, AIDS.
[7] S. Chanprasertyothin,et al. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance , 2009, Endocrine.
[8] K. Gyllensten,et al. Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells , 2009, Molecular Pharmacology.
[9] R. Monge-Rojas,et al. Components of the Metabolic Syndrome among a Sample of Overweight and Obese Costa Rican Schoolchildren , 2009, Food and nutrition bulletin.
[10] S. Khalifé,et al. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. , 2009, European journal of endocrinology.
[11] S. Booth,et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. , 2009, Journal of NutriLife.
[12] K. Arastéh,et al. Efavirenz-induced osteomalacia. , 2009, AIDS.
[13] S. Mallal,et al. Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy , 2008, AIDS.
[14] F. Sweep,et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. , 2008, AIDS research and human retroviruses.
[15] N. Wareham,et al. Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.
[16] H. Wand,et al. Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria , 2007, Diabetes Care.
[17] P. Glendenning,et al. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays , 2006, Annals of clinical biochemistry.
[18] M. Visser,et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. , 2005, The Journal of clinical endocrinology and metabolism.
[19] C. Mantzoros,et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. , 2003, The Journal of clinical endocrinology and metabolism.
[20] S. Epstein,et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. , 1985, The Journal of clinical investigation.